Member Info for Nolupus

DesAtoZ,

The at home cohort is still being recruited so results timescale is difficult to jauge at this time ...
The Future RNS stating that the last patient has started the trial will allow us to estimate the time to readout so we will just have to be patient until then ..

As far as the numbers of patients ( 100 ) we have to remember that this is only one cohort of the P2 clinical trial . The at home patients results will be added to the hospital patients 120 ( upwards if possible as. 400 possible in total estimated numbers on the clinical trial website )
Data is king so the more patients trialed the better , imo

We have passed a major milestone with the hospital results , and the SP has shooted up in response to that milestone achievement , Rich

Where the SP goes from here will be sentiment based on further milestones accomplishments .
We have major newsflow to drive the sp over the coming months but as usual the sp will move in between fixed boundaries ( ranges ) .

At this time we are in a 160-240 range , which can be broken up or down , imv
In chartered territory in exceptional times so be ready for the roller coaster :-)

If we see TRUmp with a nebulizer puffing away , well that would be a good indication imv :-))

Of TRUmp is trumpeting a treatment , it may mean that some US company has found a treatment or is buying or partnering a treatment ....

Now it's a bit early to know if we are involved so we will just have to wait and see

Halfbutt ,

If she amuses you , that's great for you but
I have to say that anyone who changes their names every second week and who loves/ hates you every second day has some ´ issues ´ to work out or has some secondary agenda ... whatever .. i am now ignoring her rants and raves

I would imagine that SYN are negotiating with many parties under NDA and that COPD and COVID interim results are on the table .....

We will find out very quickly but I can imagine a partnership with a major pharma resulting in a 10-30 % stake in SNG being part of the deal

WIN WIn for all

A move from Aim ?

I have to agree with Rich that it should' nt be on the cards at this stage as the priority should now be on the clinical and partnering level .imo

A secondary listing on the Nasdaq would be great in the future but i can't really see the point of that for the moment :-)

Scoredagainststeps,

I am not a very good trader , because I believe I am an investor :-)

There's a huge difference, imo

Tils , has the potential to become a major International Biotech / pharma, imo
Their pipeline is just enormous and if they can proceed with even just one or two of their molecules to market , they will get that status and we will reap the benefits.

Some here will look at the short term prospects like Stemprinter whilst others will be taking the long term view but best of luck to us all :-)

Miggy,

Up to now, Sng was a little known small British biotech with no real blockbuster potential...Covid 19 came along and Synairgen saw the potential and worked hard to show the world that their science was sound . Like us they took a mesured risk and are now seeking to reap the rewards by showing very solid Data on the hospital patients .
They will imo have to keep the ball rolling now with the ´ at home patients ´ to finish this P2 clinical trial and sign up a major to get even bigger limelight and ressources to push SNG001 over the regulatory approvals and onto the market.
These are extraordinary times and COvid 19 has brought the spotlight on SNG, and we can just hope that for the good of mankind ( and our portfolio) that SNG can play a major role against COvid 19

Data is king ...

It's under the radar :-)

Diversified ,

Good to see you here as well as Faron....
We should have plenty of news in the near future here and there :-)

Best of luck to you

Keep it up Darren , we are all listening to you of course :-))

Guys ,

Hold out for £5-10 billion , if you Wish ...

I will be long gone by then :-)

Eyes to the sky, but keep the feet on the ground :-)

Not me :-)

Or should I say , NOt yet :-)

THe three professors are not the only ´ paper millionnaires ´ thanks to believing in Synairgen :-)

All the best to them

Ghia ,

NEws did'nt land out of the blue :-)

It was expected by a few on the 20th or the 21st at the latest :-))

Jackman,

Have to agree , Richard and his team are doing all they can to remove the risks so to maximise the licensing/partnering/ takeover value so we will just let them get on with it ....
Every milestone will increase the valuation so sit back and enjoy the ride :-)

Was waiting for that 150 Top up

Had to average up again and now just waiting on the news ...

Sng are now in the front of the race to 300 so we have a bit of catching up to do here :-)